Print Page   |   Contact Us   |   Sign In
Community Search
Featured Members
ERNEST O. ABOAGYE Esq2016 AGM Planning C'ttee Chair
HAYFORD N. BRAKOWins International Entrepreneurship Challenge

This section will be used for adverts.
Pharmaceutical Companies can advertise here.
Adverts will be rated and run on monthly basis.
it will be first come first served basis

Available at the PSGH secretariat
  • British National Formulary 
    Book by Royal Pharmaceutical Society of Great Britain and British Medical Association
  • The British National Formulary is a pharmaceutical reference book that contains a wide spectrum of information and advice on prescribing and pharmacology, along with specific facts and details about medicines.
  • PSGH CLOTH and other materials
  • Available at the PSGH Secretariat

  • News & Press: FDA

    New FDA CEO outlines vision

    Sunday, February 19, 2017   (0 Comments)
    Posted by: Frank KUMI, Editor
    Share |

    For over 26 years, the newly appointed Chief Executive Officer (CEO) of the Food and Drugs Authority (FDA), Mrs Delese Mimi Darko, has worked with the authority in various capacities.

    She took over leadership of the FDA after the former CEO, Mr Hudu Mogtari, was relieved of his post by President Nana Addo Dankwa Akufo-Addo.

    Experience and professionalism
    Mrs Darko, who is currently one of the oldest workers, started work with the FDA which was then known as the Pharmacy Board and later split to Food and Drugs Board and the Pharmacy Council and then finally became the Food and Drugs Authority.

    The first female to head the institution, she is also the first CEO to have been appointed from within.

    Mrs Darko was the one who designed the logo of the FDA and has worked in every department of the institution, starting from the laboratory, rising through the ranks to the position of the Head of Safety, Monitoring and Clinical Trial Division, a position she held until her current appointment.

    Through her long service and expertise, the FDA was nominated and recognised by the NEPAD/African Medicines Regulation Harmonisation (AMRH), Regional Centres Regulatory Excellence in three critical areas namely medicines safety (pharmacovigilance), clinical trials and drug registration.

    She single-handedly led a collaboration of the FDA with the UK-MHRA in the area of medicine safety which is currently multi-divisional at the FDA with anti-counterfeiting as one of the key areas of support.

    Mrs Darko also served as an expert advisor on the African Regulators Network (ARN) and worked tirelessly to ensure harmonisation of regulatory systems across Africa.


    Health and safety
    Outlining her vision in an interview, she said one of her priorities was to improve health and safety, adding that if a product was not accepted internationally, it should not be allowed in Ghana.

    “Safety is across the board, Ghanaians should not be less safe than somebody staying in America and that is my prime focus for Ghanaians to ensure that what is good over there, is also good for us.

    “So we need to look at what our stakeholders are doing, compared to what is being done internationally and place ourselves there,” Mrs Darko explained, citing for instance that there were certain things in the palm oil from Ghana that were found at the international level as unsafe and was banned and yet was accepted in the country.

    She said that should not be allowed to happen again, insisting that whatever was not safe in the United Kingdom (UK) should also not be safe in Ghana.

    Mrs Darko explained that the FDA did not exist in a vacuum, “we align ourselves with other regulatory agencies. We have to make sure that we keep up with what is happening internationally.”

    “So if internationally they are not allowing certain things, we cannot sit in Ghana and say something is not safe internationally but we will allow it in Ghana,” she said.


    Growth of local industry
    On local industry, Mrs Darko said the industry had to grow to create jobs for Ghanaians, stressing that the country could no longer continue to rely on importation.

    “We do a lot of importation. It is good but importation does not create jobs,” she said, recalling that about 12 years ago, the FDA had the vision of ensuring that the manufacturing industry in the country had to grow.

    She acknowledged that such a decision might not be popular with some industry players, explaining that in going along the international standards, “you will have a fight on your hands because there are certain things that you will not allow the industry to continue doing.”

    Mrs Darko is credited with stopping the use of teaspoon or tablespoon as a form of measurement in administering medication, a decision she said was fiercely resisted by industry players as that was seen as an additional cost to the producer.

    Source: Daily Graphic

    Sign In
    Sign In securely
    Latest News
    Online Surveys

    Every PHARMACIST visiting this new PSGH WEBSITE is encouraged to UPDATE his/her PERSONAL and PROFESSIONAL PROFILES for the society, by logging in to the MEMBERS ONLY SECTION, with their default usernames and passwords (under SIGN IN at the top right rail) using psghxxxx as username and xxxxpsgh as password (where xxxx is the professional membership number).

    After signing in, please FOLLOW THE FOLLOWING INSTRUCTIONS to update your profile:
    Look for and Click on Manage Profile under My Profile (at the Top Right Rail).
    Click on Edit Bio under Information & Settings.
    Under Account Information, First Change your password, and then provide your current Email addressand confirm it. (note that your username cannot be changed).
    Under Personal Information, provide all the necessary information including: Gender, Title and Full Name, Addresses, Contact numbers etc.
    Under Professional Information, provide all the necessary information, Organisation, Type of Employment, Job Title, Addresses and Contact details etc.
    Kindly indicate the Area/s of Practice, Regional Branch/Chapter, Practice Group Association, Interest Group Association, 
    Also provide the Pharmacy School/University Attended with years, Other Institutions attended with years as well as Qualifications/Degrees obtained with years.
    Additional Information can be provided at your discretion.
    After completing the entries click SAVE CHANGES 

    Members of the PSGH are encouraged to join the appropriate groups for greater participation and communication with such groups.
    Click on Group from the Top Menu.
    Select and click the Interest group, Practice group and Regional Branch which you belonged to or intend to join.
    Then Click on Request Membership.
    You request will be fulfilled by the group Administrator, after which you become a member of the group.
    Note that request cannot be made to groups like Committees and Directorates. (That will be assigned by the Administrator).


    Feel free to browse through the site and member only areas to acquaint yourself.
    Training will be offered at the respective group meetings when the secretariat is appropriately notified.

    This website and member community can be used for several purposes, besides having your profile, Including:
    Calendar, News, Quizzes, Surveys, CPD, Conference Registration, Advertising, Announcements, Networking, Social Interaction, Forums, Career center, Publications, Ecommerce, Online Store, Dues payment etc.

    More features will be introduced gradually. We only need your profile and groups now to begin with.

    Thank you.

     PSGH is on a journey… get on board. Amicus Humani Generis.